Mark G. Malkin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mark G. Malkin has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Herbert B. Newton
Neuro-Oncology Center, CNS Oncology Program, Advent Health Cancer Institute, Advent Health Medical Group, Orlando, FL, United States
3 shared publications - Abhijit Guha
Darla Moore School of Business, University of South Carolina
1 shared publication Abhik Ray-Chaudhury
1 shared publication- Adrienne C. Scheck
Department of Child Health, University of Arizona College of Medicine–Phoenix
1 shared publication - Alicia M. Zukas
Division of Neuro-Oncology, Department of Neurosurgery, Medical University of South Carolina, Charleston, SC, United States
1 shared publication Alicia Zukas
Division of Neuro-Oncology, Virginia Commonwealth University, Richmond, VA
1 shared publication
Latest Publications
- 18 March 2022
- Published by Elsevier
- p. 635-646
Supportive care
- 1 March 2019
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 19 (3) , e129-e141
Autologous Stem-Cell Transplantation for Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis
- 1 March 2019
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 19 (3) , e129-e141
Autologous Stem-Cell Transplantation for Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis
- Open Access
- 1 January 2013
- Published by Herbert Publications PVT LTD in journal of Cancer Therapeutics and Research
- Vol. 2 (1) , 7
Cognitive Performance among Breast Cancer Survivors Treated with Aromatase Inhibitors
Background: The use of aromatase inhibitor (AI) therapy is increasing due to efficacy in decreasing breast cancer recurrence. There are theoretical reasons for concern about the effects of AI's on cognition,
- 1 January 2013
- Published by Herbert Publications PVT LTD in journal of Cancer Therapeutics and Research
- Vol. 2 (1) , 7
Open AccessCognitive Performance among Breast Cancer Survivors Treated with Aromatase Inhibitors
Background: The use of aromatase inhibitor (AI) therapy is increasing due to efficacy in decreasing breast cancer recurrence. There are theoretical reasons for concern about the effects of AI's on cognition,
- 1 January 2006
- Published by Elsevier
Contributors
- 1 January 1997
- Published by Georg Thieme Verlag KG in Seminars in Neurology
- Vol. 17 (03) , 219-226
Ethical Issues in Neuro-Oncology
Ethical issues and dilemmas are common in patients with brain tumors and other neuro-oncologic diseases. Basic knowledge of ethical principles and theory is essential for the day-to-day care of these patients, which often involves life and death decisions. The most important ethical principles include respect for autonomy, justice, beneficience, and nonmaleficence. The application of these principles is important for resolving ethical questions related to neuro-oncology patients such as discussing diagnosis and prognosis, whether or not to initiate therapy (including clinical trials), quality of life during and after treatment, when it is appropriate to stop treatment, if hospice care should be implemented, and pain control. Frequent consideration of these basic ethical principles will assist physicians during the decision-making process and improve their ability to make sound choices.
- 1 January 1997
- Published by Georg Thieme Verlag KG in Seminars in Neurology
- Vol. 17 (03) , 219-226
Ethical Issues in Neuro-Oncology
Ethical issues and dilemmas are common in patients with brain tumors and other neuro-oncologic diseases. Basic knowledge of ethical principles and theory is essential for the day-to-day care of these patients, which often involves life and death decisions. The most important ethical principles include respect for autonomy, justice, beneficience, and nonmaleficence. The application of these principles is important for resolving ethical questions related to neuro-oncology patients such as discussing diagnosis and prognosis, whether or not to initiate therapy (including clinical trials), quality of life during and after treatment, when it is appropriate to stop treatment, if hospice care should be implemented, and pain control. Frequent consideration of these basic ethical principles will assist physicians during the decision-making process and improve their ability to make sound choices.